The dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35 h later for the prevention of OHSS

Engmann, 2008, Fertil. Steril., 89, 84, 10.1016/j.fertnstert.2007.02.002

Humaidan, 2011, Copenhagen Gn RHATWG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice?, Hum. Reprod. Update, 17, 510, 10.1093/humupd/dmr008

Kol, 2004, Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome, Fertil. Steril., 81, 1, 10.1016/j.fertnstert.2003.05.032

Humaidan, 2005, GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study, Hum. Reprod., 20, 1213, 10.1093/humrep/deh765

Kolibianakis, 2005, A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists, Hum. Reprod., 20, 2887, 10.1093/humrep/dei150

Beckers, 2003, J. Clin. Endocrinol. Metab., 88, 4186, 10.1210/jc.2002-021953

Fauser, 2002, Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization, J. Clin. Endocrinol. Metab., 87, 709, 10.1210/jcem.87.2.8197

Griffin, 2012, Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders, Fertil. Steril., 97, 1316, 10.1016/j.fertnstert.2012.03.015

Humaidan, 2013, GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients, Hum. Reprod., 28, 2511, 10.1093/humrep/det249

Bodri, 2013, Low-dose hCG supplementation after GnRH agonist triggering: don't be too quick on the trigger, Hum. Reprod., 28, 2315, 10.1093/humrep/det125

Seyhan, 2013, Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG, Hum. Reprod., 28, 2522, 10.1093/humrep/det124

Papanikolaou, 2010, Identification of the high-risk patient for ovarian hyperstimulation syndrome, Semin. Reprod. Med., 28, 458, 10.1055/s-0030-1265671

Humaidan, 2010, 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study, Fertil. Steril., 93, 847, 10.1016/j.fertnstert.2008.12.042

Engmann, 2011, In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation, Fertil. Steril., 96, 198, 10.1016/j.fertnstert.2011.04.071

Golan, 1989, Ovarian hyperstimulation syndrome: an update review, Obstet. Gynecol. Surv., 44, 430, 10.1097/00006254-198906000-00004

Boivin, 2011, The fertility quality of life (fertiqol) tool: development and general psychometric properties, Fertil. Steril., 96, 409, 10.1016/j.fertnstert.2011.02.046

Babayof, 2006, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial, Hum. Reprod., 21, 1260, 10.1093/humrep/dei475

Derkx, 1987, Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure, J. Clin. Endocrinol. Metab., 65, 349, 10.1210/jcem-65-2-349

Lenz, 1989, Tissue levels of active and total renin, angiotensinogen, human chorionic gonadotropin, estradiol, and progesterone in human placentas from different methods of delivery, J. Clin. Endocrinol. Metab., 69, 31, 10.1210/jcem-69-1-31